Intensified ADT benefits biochemical progression-free survival in biochemically relapsed prostate cancer Presented ByDr Rahul Aggarwal, University of California San Francisco, CA, USA TrialPhase 3, PRESTO ConferenceESMO 2022 17 November, 2022 00:13